BioNTech To Pilot New Malaria Jab By 2022
Jul 28, 2021 ·
53s
German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year. The ambitious turnaround time is thanks to the mRNA technology used to develop...
show more
German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year.
The ambitious turnaround time is thanks to the mRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
show less
The ambitious turnaround time is thanks to the mRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
Information
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
